Biocon share news, announcements and annual reports
NSE: BIOCONBSE: 532523Pharmaceuticals & BiotechnologyMid Cap
Biocon Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 2004
Last close ₹351.90up ₹1.20 (0.34%)BSE ₹352.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹350.70.
29 Oct: open ₹351.50, high ₹357.30, low ₹349.40
52-week range of traded prices to 29 Oct 2026
₹318.40Low, 23 Oct 2026₹447.15High, 16 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹57,349 Cr173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 115.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 64.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.69
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 1.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹399 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 31,13,378
Biocon results
124 filed, newest first. Page 1 of 3.
Aug 2026
5 Aug · Results
May 2026
7 May · Results
Feb 2026
12 Feb · Results
Nov 2025
11 Nov · Results
Aug 2025
7 Aug · Results
May 2025
8 May · Results
8 May · Results
Jan 2025
30 Jan · Results
Oct 2024
30 Oct · Results
Aug 2024
8 Aug · Results
May 2024
16 May · Results
Feb 2024
8 Feb · Results
Nov 2023
10 Nov · Results
Aug 2023
10 Aug · Results
May 2023
23 May · Results
Feb 2023
14 Feb · Results
Jul 2022
Apr 2022
28 Apr · Results
Jan 2022
20 Jan · Results
Oct 2021
21 Oct · Results
Jul 2021
22 Jul · Results
Apr 2021
28 Apr · Results
Jan 2021
21 Jan · Results
Oct 2020
22 Oct · Results
Jul 2020
23 Jul · Results
May 2020
14 May · Results
Jan 2020
23 Jan · Results
Oct 2019
23 Oct · Results
Jul 2019
25 Jul · Results
May 2019
Apr 2019
25 Apr · Results
Jan 2019
24 Jan · Results
Oct 2018
25 Oct · Results
Jul 2018
26 Jul · Results
Apr 2018
26 Apr · Results
Jan 2018
24 Jan · Results
Oct 2017
26 Oct · Results
Jul 2017
27 Jul · Results
Apr 2017
27 Apr · Results
Jan 2017
24 Jan · Results
Oct 2016
Jul 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
Apr 2015
Jan 2015